|
United Therapeutics Corp Common
(UTHR)
|
13.5 |
$1.5B |
|
2.8M |
541.83 |
|
Ascendis Pharma Ordinary Shares
(ASND)
|
12.2 |
$1.4B |
|
5.1M |
266.72 |
|
Krystal Biotech Common
(KRYS)
|
9.6 |
$1.1B |
|
2.9M |
371.67 |
|
Madrigal Pharmaceuticals Common
(MDGL)
|
8.8 |
$984M |
|
1.8M |
536.95 |
|
Argenx Se Sponsored ADR
(ARGX)
|
8.3 |
$928M |
|
1.0M |
927.77 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
8.3 |
$926M |
|
11M |
81.51 |
|
Kymera Therapeutics Common
(KYMR)
|
7.7 |
$857M |
|
7.5M |
114.67 |
|
Revolution Medicines Common
(RVMD)
|
3.9 |
$430M |
|
2.3M |
187.28 |
|
Cytokinetics Common
(CYTK)
|
3.8 |
$426M |
|
5.0M |
85.19 |
|
Celcuity Common
(CELC)
|
3.2 |
$356M |
|
3.4M |
104.62 |
|
Structure Therapeutics Sponsored Ads
(GPCR)
|
3.2 |
$352M |
|
6.6M |
53.67 |
|
Xenon Pharmaceuticals Common
(XENE)
|
3.1 |
$349M |
|
5.8M |
60.36 |
|
Definium Therapeutics Common
(DFTX)
|
3.0 |
$338M |
|
7.2M |
47.04 |
|
Uniqure Nv Common
(QURE)
|
2.8 |
$310M |
|
6.7M |
46.06 |
|
Vera Therapeutics Common
(VERA)
|
2.2 |
$246M |
|
5.7M |
42.91 |
|
Taysha Gene Therapies Common
(TSHA)
|
1.5 |
$163M |
|
24M |
6.81 |
|
Ocular Therapeutix Common
(OCUL)
|
1.1 |
$123M |
|
13M |
9.82 |
|
Damora Therapeutics Common
(DMRA)
|
0.9 |
$98M |
|
3.8M |
26.01 |
|
Hemab Therapeutics Hldgs Common
|
0.6 |
$71M |
|
1.9M |
36.73 |
|
Gh Research Ordinary Shares
(GHRS)
|
0.4 |
$48M |
|
1.8M |
26.88 |
|
Viridian Therapeutics Common
(VRDN)
|
0.4 |
$46M |
|
2.5M |
18.37 |
|
Septerna Common
(SEPN)
|
0.4 |
$45M |
|
1.3M |
33.49 |
|
Avalo Therapeutics Common
(AVTX)
|
0.4 |
$43M |
|
2.3M |
18.48 |
|
Faeth Therapeutics Common
(FTH)
|
0.3 |
$36M |
|
1.4M |
25.00 |
|
Whitehawk Therapeutics Common
(WHWK)
|
0.1 |
$13M |
|
2.8M |
4.58 |
|
Lexeo Therapeutics Common
(LXEO)
|
0.1 |
$6.9M |
|
1.5M |
4.66 |